Zhang Ruifang, Yan Fei, Chen Yu
Department of Ultrasound The First Affiliated Hospital of Zhengzhou University Zhengzhou Henan Province 450052 P. R. China.
Paul C. Lauterbur Research Center for Biomedical Imaging Institute of Biomedical and Health Engineering Shenzhen Institutes of Advanced Technology Chinese Academy of Sciences Shenzhen 518055 P. R. China.
Adv Sci (Weinh). 2018 Oct 17;5(12):1801175. doi: 10.1002/advs.201801175. eCollection 2018 Dec.
Titania semiconductors can be activated by external physical triggers to produce electrons (e) and holes (h) pairs from the energy-band structure and subsequently induce the generation of reactive oxygen species for killing cancer cells, but the traditional ultraviolet light with potential phototoxicity and low-tissue-penetrating depth as the irradiation source significantly hinders the further in vivo broad biomedical applications. Here, the very-recent development of novel exogenous physical irradiation of titania semiconductors for tumor-specific therapies based on their unique physiochemical properties, including near infrared (NIR)-triggered photothermal hyperthermia and photodynamic therapy, X-ray/Cerenkov radiation-activated deep-seated photodynamic therapy, ultrasound-triggered sonodynamic therapy, and the intriguing synergistic therapeutic paradigms by combined exogenous physical irradiations are in focus. Most of these promising therapeutic modalities are based on the semiconductor nature of titania nanoplatforms, together with their defect modulation for photothermal hyperthermia. The biocompatibility and biosafety of these titania semiconductors are also highlighted for guaranteeing their further clinical translation. Challenges and future developments of titania-based therapeutic nanoplatforms and the corresponding developed therapeutic modalities for potential clinical translation of tumor-specific therapy are also discussed and outlooked.
二氧化钛半导体可通过外部物理触发从能带结构中产生电子(e)和空穴(h)对,随后诱导活性氧的产生以杀死癌细胞,但传统的紫外线作为辐照源具有潜在的光毒性且组织穿透深度低,这严重阻碍了其在体内进一步广泛的生物医学应用。在此,基于二氧化钛半导体独特的物理化学性质,用于肿瘤特异性治疗的新型外源性物理辐照的最新进展成为焦点,包括近红外(NIR)触发的光热高温疗法和光动力疗法、X射线/切伦科夫辐射激活的深部光动力疗法、超声触发的声动力疗法,以及通过联合外源性物理辐照的有趣协同治疗模式。这些有前景的治疗方式大多基于二氧化钛纳米平台的半导体性质,以及它们对光热高温疗法的缺陷调制。还强调了这些二氧化钛半导体的生物相容性和生物安全性,以确保它们进一步的临床转化。还讨论并展望了基于二氧化钛的治疗性纳米平台的挑战和未来发展,以及为肿瘤特异性治疗的潜在临床转化而开发的相应治疗模式。